Life is Evolutionary with or without me – Sharing information is what I can do, it is Powerful and Evolutionary for all.
CCA Articles Library
Articles: Genereal
TIPS: For Patients with Rare Cancer, Tips on Finding Expert Treatment
Wagner also recommends that patients seek out physicians with experience in their particular disease. To find them, he suggests checking with one’s primary oncologist, joining an online patient support group, and doing an Internet search for research studies involving one’s particular type of cancer. Authors of these studies may be, or know of, experts in that form of cancer.
Chemo: A retrospective analysis of gemcitabine and nab-paclitaxe
Surgery: Curative Surgery
Cause: Doctors battle Cancer Causing Fish: Thailand: (June 2017)
Chemo: Drug capecitabine improves survival by almost a quarter (2017)
How: USA: Cholangiocarcinoma: Current Knowledge & Developments Jan 2017
Surgery: Resectable Cholangiocarcinoma (2016)
Articles: Containing People + Patients
TIPS: For Patients with Rare Cancer, Tips on Finding Expert Treatment
Wagner also recommends that patients seek out physicians with experience in their particular disease. To find them, he suggests checking with one’s primary oncologist, joining an online patient support group, and doing an Internet search for research studies involving one’s particular type of cancer. Authors of these studies may be, or know of, experts in that form of cancer.Li Ka-shing:’ One word for it – hope’: Hong Kong’s richest man donates $4.5m to Sydney cancer trial
Hong Kong’s richest man Li Ka-shing | References to AFL’s Jarryd Roughead (Melonoma) | Tony Biddle (mesothelioma)
Articles: Immunotherapy
ABC TV: Immno: Ask the Doctor Series 2 Episode 9: Immunity Wars
Video of Keytruda actually eating /eliminating tumors in real time.
T Cell: Jan 2019: Isolating T Cells for Adoptive Immunotherapy
Immunotherapy now occupies a position of immense promise in cancer therapeutics. Here, we speak with researchers about the methods they use in immunotherapy projects. read more
Related: CRP may predict survival after immunotherapy for lung cancer
Opdivo: Beneath the Surface: Advancing Treatment for Cholangiocarcinoma
> “One of my patients had a spontaneously occurring MSI-high mutation in her intrahepatic cholangiocarcinoma that had widely metastasized and progressed on chemotherapy,” Kelley continues. “She was treated with pembrolizumab as part of a clinical trial, and after two years, no residual tumor could be found. She then stopped the drug and continues to have an ongoing complete response, now approaching four years after she initially started treatment on the trial.”
Opdivo :USA:FDA Approves Opdivo for Certain Patients
PDL-1: Cancer Cells Can Flood Bloodstream with Protein ‘Warriors’ Against Immune Response.
> Anti-cancer therapies target and block this interaction (PD-L1 with its PD-1 receptor) to promote T-cell activation and stimulate anti-canter immune responses. However, many patients with PD-L1-producing cancers do not respond to these therapies.
Keytruda: Keytruda and Chemotherapy Combo Now 1st-Line Treatment
Related: High Nitrogen Levels Can Increase Cancer Cell Growth, But Also Enhance Immunotherapy Response
Immuno: Immuno: Pseudoprogression
Opdivo: Opdivo and Keytruda hold hope
Related: Turning Cancer on itself : Harvard Medical School
Check Point: Survival Benefits of Checkpoint Inhibitors 2-times Higher in Men with Advanced Cancers Than Women, Study Finds
